CancerCompass is dedicated to provided you with the most up to date cancer information and news. Visit our website to find all our articles on Gynecological Cancer News http://www.cancercompass.com/gynecological-cancer-news.htm Sun, 08 Nov 2009 00:00:00 GMT Sun, 08 Nov 2009 00:00:00 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ Drugs used to treat psychiatric disorders are highly effective at killing cancer cells, opening up potential new lines of treatments. Dr Louise Lurze-Mann of the University of NSW School of Biotechnology and Biomolecular Sciences was talking with psychiatric researchers at the University of Queensland when they mentioned that people with diseases like schizophrenia appear to have low rates of cancer, despite being more inclined to smoke than the general population. http://www.cancercompass.com/cancer-news/article/32367.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT A Dutch study that included nearly 90,000 women finds that liquid-based cytology, a commonly used alternative to conventional Pap tests, is not superior to Pap tests for the detection of cervical cancer precursors or cancer, according to a study in the October 28 issue of JAMA. http://www.cancercompass.com/cancer-news/article/32359.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT Nektar Therapeutics announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum- resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers. http://www.cancercompass.com/cancer-news/article/32360.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT Results of the FDA pivotal clinical trial for the LightTouch(TM) Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI). http://www.cancercompass.com/cancer-news/article/32362.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT It's a safe bet to presume there are soup recipes in today's column because it's colder, furnaces are running and it just seems like a fall thing to do. http://www.cancercompass.com/cancer-news/article/32365.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT U.S. scientists say they have discovered a small molecule that inhibits the actions of a protein cancer cells require for survival. The researchers said they determined the molecule, called PES, inhibits a type of protein called a heat-shock protein that helps cells survive heat, lack of nutrients and other cell-damaging conditions. http://www.cancercompass.com/cancer-news/article/32368.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists. http://www.cancercompass.com/cancer-news/article/32371.htm CancerCompass Fri, 06 Nov 2009 00:00:00 GMT Mollie Katzen's latest cookbook urges beginners to take on her challenge with easy recipes, such as this acorn squash entree. Use plain raw almonds, not roasted or salted, Katzen writes, and don't chop them too fine. You can cook the rice and bake the acorn squash at the same time. http://www.cancercompass.com/cancer-news/article/32356.htm CancerCompass Wed, 04 Nov 2009 00:00:00 GMT If you're watching your weight, soup can be deceptive. What could be more harmless for lunch or a light dinner? Not so fast. Depending on the recipe, some soups are full of cream and cheese, or sometimes worse, they start with a roux. In place of cream and butter, add flavor to soup with lots of vegetables, beef broth and dried and fresh herbs. http://www.cancercompass.com/cancer-news/article/32357.htm CancerCompass Wed, 04 Nov 2009 00:00:00 GMT Drink up, coffee lovers. Not only is coffee aromatic and delicious, it's good for you. Who says? None other than Harvard Medical School. Once considered questionable for your health, it turns out that the beloved beverage is actually healthful in moderation. That means a few cups a day. http://www.cancercompass.com/cancer-news/article/32341.htm CancerCompass Tue, 03 Nov 2009 00:00:00 GMT Does it make sense to offer cancer screenings to older adults? Experts' opinions vary. The Tribune asked several leading organizations to describe their policies for people considered to be low risk, without symptoms of potential illness. http://www.cancercompass.com/cancer-news/article/32319.htm CancerCompass Wed, 28 Oct 2009 00:00:00 GMT Cancer patients don't have time to waste, yet many must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the University of Virginia Health System have developed a breakthrough method that could one day eliminate this trial and error approach to treating many cancers. http://www.cancercompass.com/cancer-news/article/32299.htm CancerCompass Sat, 24 Oct 2009 00:00:00 GMT People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs. A new, federally-funded study by Queen's University researchers has found that taking the drugs together is a more effective treatment than taking either of them individually. http://www.cancercompass.com/cancer-news/article/32310.htm CancerCompass Wed, 28 Oct 2009 00:00:00 GMT British medical scientists say they've demonstrated that unusual metal compounds can be used to form effective cancer drugs. Researchers at the University of Leeds and the University of Warwick said such metals can form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs. http://www.cancercompass.com/cancer-news/article/16478.htm CancerCompass Wed, 21 Oct 2009 00:00:00 GMT The U.S. Food and Drug Administration (FDA) on Monday approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women age 10 to 25. http://www.cancercompass.com/cancer-news/article/16466.htm CancerCompass Tue, 20 Oct 2009 00:00:00 GMT GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX(R) [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25). http://www.cancercompass.com/cancer-news/article/16452.htm CancerCompass Sat, 17 Oct 2009 00:00:00 GMT A new study, 'Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial,' is now available. In advanced ovarian cancer, maximal efforts have to be attemptedto achieve optimal cytoreduction, as this represents the keystone in the therapeutic management. http://www.cancercompass.com/cancer-news/article/16442.htm CancerCompass Thu, 15 Oct 2009 00:00:00 GMT According to recent research from the United States, A majority of women with ovarian cancer will face recurrent disease despite receiving aggressive chemotherapy at the time of diagnosis. Given the complex medical and psychosocial needs of women with ovarian cancer and the time constraints within busy clinical settings, providing women with the necessary education related to their disease and treatments can be challenging. http://www.cancercompass.com/cancer-news/article/16453.htm CancerCompass Sat, 17 Oct 2009 00:00:00 GMT In honor of National Breast Cancer Awareness Month, a group of women known as the BRAC (Be Ready Against Cancer) Pack has stepped up its efforts to encourage genetic testing for breast and ovarian cancer. The women are advocates for BRACAnalysis, a lab test that looks for mutations on the BRCA1 and BRCA2 genes, which are associated with an increased risk of breast and ovarian cancer. http://www.cancercompass.com/cancer-news/article/16443.htm CancerCompass Thu, 15 Oct 2009 00:00:00 GMT The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Cervical Cancer Screening to provide further recommendations for a subset of women with conflicting results on cervical cytology/Pap tests and Human papillomavirus (HPV) High Risk DNA tests. http://www.cancercompass.com/cancer-news/article/16444.htm CancerCompass Thu, 15 Oct 2009 00:00:00 GMT